Eli Lilly
LLY Mega CapHealthcare · Drug Manufacturers - General
Aggiornato: May 2, 2026, 22:05 UTC
Metriche Chiave
Analisi della Valutazione
Informazioni sull'Azienda
Eli Lilly Stock at a Glance
Eli Lilly (LLY) is currently trading at 821,74 € with a market capitalization of 735,3 Mrd. €. The trailing P/E ratio stands at 34.25x, with a forward P/E of 22.06x. The 52-week range spans from 532,10 € to 967,29 €; the current price is 15% below the yearly high. Year-over-year revenue growth stands at +55.5%. The net profit margin stands at 34.99%.
💰 Dividendo
Eli Lilly pays an annual dividend of 5,31 € per share, representing a yield of 0.65%. The payout ratio stands at 22.13%.
📊 Raccomandazioni degli Analisti
29 analysts rate Eli Lilly (LLY) on consensus: Comprare. The average price target is 1.025,48 €, implying +24.79% from the current price. Analyst price targets range from 725,07 € to 1.279,54 €.
Tesi di Investimento: Punti di Forza e Debolezze
- Strong revenue growth of 55.5% YoY
- Profitable with 34.99% net margin
- High gross margin of 82.83% — indicates pricing power
- Analyst consensus: Buy
- –Currently flagged as overvalued
- –High leverage (D/E 165.31)
Panoramica Tecnica
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profilo di Rischio
The data points to relatively defensive market behavior, higher leverage relative to equity.
Dati di Trading
💵 Info Dividendo
Azioni Correlate nello Stesso Settore
Where can I buy Eli Lilly?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
